Replies to post #20707 on Mymetics Corp (MYMX)

[Work Harder]

Human ebola virus species and compositions and methods thereof

Liposomes, Virosomes, cochleates, and immune stimulating complex, which is sold under the trademark ISCOM.

Current Assignee Centers of Disease Control and Prevention CDC

https://patents.google.com/patent/CA2741523A1/en

ISCOM technology-based Matrix M[trademark] adjuvant: success in future vaccines relies on formulation

https://go.gale.com/ps/anonymous?id=GALE%7CA283878182&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=14760584&p=AONE&sw=w

Berlin

Novavax Ready to Produce Nearly 3 Billion Coronavirus Vaccine Doses (With a Little Help From Friends)

https://www.newsbreak.com/news/1615804024677/novavax-ready-to-produce-nearly-3-billion-coronavirus-vaccine-doses-with-a-little-help-from-friends

[Work Harder]

Here it is

virosome component protein [Vaccinia virus]
GenBank: ALF36217.1

https://www.ncbi.nlm.nih.gov/protein/ALF36217

From that

c Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany

d Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia, USA

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645304/

However, it is suggested that the VACV-IOC used in the 1970s originated from the Beaugency strain (J. A. Espmark to D. A. Henderson, correspondence on March 31, 1969, file 88-001-10, Sanofi Pasteur Archives [Connaught Campus]) that probably constituted the first animal-based vaccine samples imported to Brazil in 1887 from Chambon Institute, France


Affymetrix to Acquire eBioscience Nov. 30, 2011
- eBioscience is a leader in flow cytometry for oncology

https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2011/Affymetrix-to-Acquire-eBioscience/default.aspx

https://en.wikipedia.org/wiki/Affymetrix

In 2010 it only took a few days for Millipore Corporation (NYSE: MIL) to find a buyer willing to outbid Thermo Fisher Scientific Inc. (NYSE: TMO). Millipore agreed to be acquired by Merck KGaA (FWB: MRK) of Darmstadt, Germany. Merck will pay about $7.2 billion for Millipore, which tops a reported bid of $6 billion made by Thermo Fisher